For: | Feng DY, Sun Y, Cheng RX, Ouyang XM, Zheng H. Effect of hepatitis C virus nonstructural protein NS3 on proliferation and MAPK phosphorylation of normal hepatocyte line. World J Gastroenterol 2005; 11(14): 2157-2161 [PMID: 15810084 DOI: 10.3748/wjg.v11.i14.2157] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i14/2157.htm |
Number | Citing Articles |
1 |
Dowluru S.V.G.K. Kaladhar, Tantravahi Srinivasan. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 257 doi: 10.1016/B978-0-323-98806-3.00005-2
|
2 |
Aqsa Ikram, Bisma Rauff, Badr Alzahrani, Faryal Mehwish Awan, Ayesha Obaid, Anam Naz, Salik Javed Kakar, Hussnain Ahmed Janjua. Integrated analysis to study the interplay between post-translational modifications (PTM) in hepatitis C virus proteins and hepatocellular carcinoma (HCC) development. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-19854-6
|
3 |
Urania Georgopoulou, Alexios Dimitriadis, Pelagia Foka, Eirini Karamichali, Avgi Mamalaki. Hepcidin and the iron enigma in HCV infection. Virulence 2014; 5(4): 465 doi: 10.4161/viru.28508
|
4 |
Carole-Anne Martineau, Nathalie Rivard, Martin Bisaillon. From viruses to cancer: exploring the role of the hepatitis C virus NS3 protein in carcinogenesis. Infectious Agents and Cancer 2024; 19(1) doi: 10.1186/s13027-024-00606-2
|
5 |
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad. Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection. World Journal of Hepatology 2017; 9(36): 1305-1314 doi: 10.4254/wjh.v9.i36.1305
|
6 |
Ben Ponvilawan, Thanitsara Rittiphairoj, Nipith Charoenngam, Pongprueth Rujirachun, Phuuwadith Wattanachayakul, Surapa Tornsatitkul, Patompong Ungprasert. Association Between Chronic Hepatitis C Virus Infection and Esophageal Cancer. Journal of Clinical Gastroenterology 2022; 56(1): 55 doi: 10.1097/MCG.0000000000001532
|
7 |
Simmone D'souza, Keith CK Lau, Carla S Coffin, Trushar R Patel. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(38): 5759-5783 doi: 10.3748/wjg.v26.i38.5759
|
8 |
Mohd Amir F. Abdullah, Sarah M. McWhirter, Zucai Suo. Modulation of Kinase Activities In Vitro by Hepatitis C Virus Protease NS3/NS4A Mediated-Cleavage of Key Immune Modulator Kinases. Cells 2023; 12(3): 406 doi: 10.3390/cells12030406
|
9 |
K. Zscharnack, R. Kessler, F. Bleichert, J. P. Warnke, K. Eschrich. The PFKFB3 splice variant UBI2K4 is downregulated in high‐grade astrocytomas and impedes the growth of U87 glioblastoma cells. Neuropathology and Applied Neurobiology 2009; 35(6): 566 doi: 10.1111/j.1365-2990.2009.01027.x
|
10 |
T. Vescovo, G. Refolo, G. Vitagliano, G.M. Fimia, M. Piacentini. Molecular mechanisms of hepatitis C virus–induced hepatocellular carcinoma. Clinical Microbiology and Infection 2016; 22(10): 853 doi: 10.1016/j.cmi.2016.07.019
|
11 |
Zakaria Boulahtouf, Alessia Virzì, Thomas F. Baumert, Eloi R. Verrier, Joachim Lupberger. Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences. International Journal of Molecular Sciences 2022; 23(5): 2787 doi: 10.3390/ijms23052787
|
12 |
Clara Balsano, Anna Alisi. Hepatitis C virus (HCV): an RNA virus with a pro-oncogenic potential. Digestive and Liver Disease 2007; 39: S46 doi: 10.1016/S1590-8658(07)80010-7
|
13 |
Ziv Ben Ari, Ella Weitzman, Michal Safran. Oncogenic Viruses and Hepatocellular Carcinoma. Clinics in Liver Disease 2015; 19(2): 341 doi: 10.1016/j.cld.2015.01.006
|
14 |
Nisha Sahu, Samrat Rakshit, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 33 doi: 10.1016/B978-0-323-98806-3.00023-4
|
15 |
Kung-Chia Young, Chyi-Huey Bai, Hui-Chen Su, Pei-Ju Tsai, Chien-Yu Pu, Chao-Sheng Liao, Yu-Min Lin, Hsin-Wen Lai, Lee-Won Chong, Yau-Sheng Tsai, Chiung-Wen Tsao. Fluoxetine a novel anti-hepatitis C virus agent via ROS-, JNK-, and PPARβ/γ-dependent pathways. Antiviral Research 2014; 110: 158 doi: 10.1016/j.antiviral.2014.08.002
|
16 |
Jun-Wu Li, Ke Li, Jing Jiang, Xiao-Liang Xu, Ze-Qi Huang. Construction of eukaryotic expression plasmid containing HCV NS3 segment and protein expression in human HL-7702 hepatocytes. World Journal of Gastroenterology 2006; 12(7): 1038-1042 doi: 10.3748/wjg.v12.i7.1038
|
17 |
Mohamed Hassan, Denis Selimovic, Abdelouahid El-Khattouti, Hanan Ghozlan, Youssef Haikel, Ola Abdelkader. Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies. World Journal of Experimental Medicine 2012; 2(2): 7-25 doi: 10.5493/wjem.v2.i2.7
|
18 |
Tomomi Kogiso, Takaomi Sagawa, Kazuhisa Kodama, Makiko Taniai, Satoshi Katagiri, Hiroto Egawa, Masakazu Yamamoto, Katsutoshi Tokushige. Hepatocellular carcinoma after direct‐acting antiviral drug treatment in patients with hepatitis C virus. JGH Open 2019; 3(1): 52 doi: 10.1002/jgh3.12105
|
19 |
Debojyoti Halder, Ashutosh Gupta, Subhasis Chakraborty, Partha Roy, Kalyan Kumar Sen. Upgraded theragnostic strategies of multivariate nano gold in the management of hepatocellular carcinoma. Nano-Structures & Nano-Objects 2024; 40: 101342 doi: 10.1016/j.nanoso.2024.101342
|
20 |
X. B. Pan, L. Wei, H. S. Chen, F. Liu, Y. Gao. Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patterns. Archives of Virology 2007; 152(6): 1159 doi: 10.1007/s00705-006-0927-4
|
21 |
Anuradha Balasubramanian, Jerome E. Groopman, Ramesh K. Ganju. Underlying Pathophysiology of HCV Infection in HIV-Positive Drug Users. Journal of Addictive Diseases 2008; 27(2): 75 doi: 10.1300/J069v27n02_09
|
22 |
Huanqin Li, Shumin Liu, Yun Lin, Xiongfei Shi, Na Du, Jing Yao, Ruiyang Liu, Yan Du, Kai Yang. Identification and Verification of Ubiquitin D as a Gene Associated with Hepatitis C Virus-Induced Hepatocellular Carcinoma. Intervirology 2022; 65(4): 195 doi: 10.1159/000525543
|
23 |
Aldona Kasprzak, Agnieszka Adamek. Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis. Hepatology Research 2008; 38(1): 1 doi: 10.1111/j.1872-034X.2007.00261.x
|